Eric Fan
Genentech
3 Papers
30 Citations
Eric Fan is an academic researcher from Genentech. The author has contributed to research in topics: Kinase & Chemistry. The author has an hindex of 3, co-authored 3 publications. Previous affiliations of Eric Fan include Merck & Co..
Chat about Author
Papers
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple Myeloma.
Xiaojing Wang,Wesley Blackaby,Vivienne Allen,Grace Ka Yan Chan,Jae H. Chang,Po-Chang Chiang,Coura Diène,Jason Drummond,Steven Do,Eric Fan,Eric Harstad,Alastair James Hodges,Huiyong Hu,Wei Jia,William Kofie,Aleksandr Kolesnikov,Joseph P. Lyssikatos,Justin Ly,Mizio Matteucci,John Moffat,Veerendra Munugalavadla,Jeremy Murray,David John Nash,Cameron L. Noland,Geoff Del Rosario,Leanne Ross,Craig Rouse,Andrew Sharpe,Dionysos Slaga,Minghua Sun,Vickie Tsui,Heidi J.A. Wallweber,Shang-Fan Yu,Allen J. Ebens +33 more
TL;DR: The compound optimization leading to GDC-0339 is reported, a potent, orally bioavailable, and well tolerated pan-Pim kinase inhibitor that proved efficacious in RPMI8226 and MM.1S human multiple myeloma xenograft mouse models and has been evaluated as an early development candidate.
34
Fluorinated piperidine acetic acids as γ-secretase modulators
Matthew G. Stanton,Jed L. Hubbs,David L. Sloman,Christopher Hamblett,Paula Andrade,Minilik Angagaw,Grace Bi,Black Regina M,Jamie L. Crispino,Jonathan C. Cruz,Eric Fan,Georgia Farris,Bethany Hughes,Candia M. Kenific,Richard E. Middleton,George N. Nikov,Peter Sajonz,Sanjiv J. Shah,Nirah H. Shomer,Alexander A. Szewczak,Flobert Tanga,Matthew T. Tudge,Mark S. Shearman,Benito Munoz +23 more
TL;DR: A novel series of difluoropiperidine acetic acids as modulators of gamma-secretase was reported, and in a 7-day safety study, rats treated orally with compound 1f did not exhibit Notch-related effects.
31
Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design.
Xiaojing Wang,Steven Magnuson,Rich Pastor,Eric Fan,Huiyong Hu,Vickie Tsui,Wei Deng,Jeremy Murray,Micah Steffek,Heidi J.A. Wallweber,John Moffat,Jason Drummond,Grace Ka Yan Chan,Eric Harstad,Allen J. Ebens +14 more
TL;DR: Using property-based drug design and co-crystal structures with Pim-1 kinase to guide analog design, this work was able to improve potency against all three Pim isoforms including a significant 10,000-fold gain against PIM-2.